Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome

NCT00767364 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

BIOLOGICAL: Oral, live, pentavalent rotavirus vaccine; RotaTeq(R)

Sponsor

Children's Hospital of Michigan

Collaborators

[object Object]
[object Object]
[object Object]